Randomised phase II study of Cediranib with or without SRC inhibition (Saracatinib) in metastatic clear cell renal cancer (RCC) patients resistant to VEGF targeted therapy

Thomas Powles, Robert Hawkins, Christy Ralph, James Larkin, Robert J Jones, Simon Chowdhury, E Boleti, Kate Fife, A. Bahl, Simon J. Crabb, A. Webb, Omar S. Din, J Dunlop, R Hill, Thomas Geldart, Duncan McLaren, P J Nathan

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Article numberLBA24A
JournalAnnals of Oncology
Volume25
Issue numberSuppl_4
Publication statusPublished - 1 Sep 2014

Cite this